Relay Therapeutics, Inc. (RLAY) — DEF 14A Filings
All DEF 14A filings from Relay Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Relay Therapeutics DEF 14A: Executive Compensation Details
— Apr 23, 2025 Risk: medium
Relay Therapeutics, Inc. filed a DEF 14A on April 23, 2025, for the fiscal year ending December 31, 2024. The filing concerns executive compensation and related -
Relay Therapeutics 2024 Annual Meeting: Director Elections & Executive Pay Vote
— Apr 23, 2024 Risk: low
Relay Therapeutics, Inc. is holding its 2024 Annual Meeting of Stockholders online on June 3, 2024, at 1:30 p.m. ET. Key agenda items include electing two Class
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX